Incannex Healthcare receives approval for proprietary drug for treating obstructive sleep apnea

Mugglehead
By Natalia Buendia CalvilloJul 6, 2023, 9:30 pm204 pts
Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL) an Australian pharmaceutical firm, has received approval to kick off a critical clinical trial on IHL-42X, its proprietary treatment for obstructive sleep apnea (OSA). The green light from the Bellberry Human Research Ethics Committee was announced Thursday…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Fluence Debuts SPYDR 3: Pioneering Fixture Upgrades Output and Efficiency for Cannabis Growers 68

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 63

Lawmakers urge Trump to act on cannabis 62

Grön, Head Change Debut Exclusive Solventless Edibles in Missouri 30

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.